LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 34

Search options

  1. Article: Commentary on "Inferior mesenteric artery aneurysm combined with renal artery stenosis in a patient with neurofibromatosis".

    Delis, Konstantinos T

    Perspectives in vascular surgery and endovascular therapy

    2006  Volume 18, Issue 3, Page(s) 221–223

    MeSH term(s) Adult ; Aneurysm/etiology ; Aneurysm/surgery ; Blood Vessel Prosthesis Implantation ; Humans ; Male ; Mesenteric Artery, Inferior ; Neurofibromatosis 1/complications ; Renal Artery Obstruction/etiology ; Renal Artery Obstruction/surgery ; Splanchnic Circulation
    Language English
    Publishing date 2006-09
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 2054424-8
    ISSN 1521-5768 ; 1531-0035
    ISSN (online) 1521-5768
    ISSN 1531-0035
    DOI 10.1177/1531003506295142
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Regarding "Practical applications of hemodynamic effect of intermittent pneumatic compression of the leg after infrainguinal arterial bypass grafting".

    Delis, Konstantinos T

    Journal of vascular surgery

    2005  Volume 41, Issue 4, Page(s) 734–735

    MeSH term(s) Graft Occlusion, Vascular/prevention & control ; Gravity Suits ; Humans ; Inguinal Canal/blood supply ; Inguinal Canal/surgery ; Leg/blood supply ; Leg/surgery
    Language English
    Publishing date 2005-04
    Publishing country United States
    Document type Letter
    ZDB-ID 605700-7
    ISSN 1097-6809 ; 0741-5214
    ISSN (online) 1097-6809
    ISSN 0741-5214
    DOI 10.1016/j.jvs.2004.10.052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The case for intermittent pneumatic compression of the lower extremity as a novel treatment in arterial claudication.

    Delis, Konstantinos T

    Perspectives in vascular surgery and endovascular therapy

    2005  Volume 17, Issue 1, Page(s) 29–42

    Abstract: Appreciation of the physiologic role of the natural muscle pumps of the lower limb in enhancing the return of venous blood promoted the development of intermittent pneumatic limb compression (IPC) systems that could activate these pumps artificially. The ...

    Abstract Appreciation of the physiologic role of the natural muscle pumps of the lower limb in enhancing the return of venous blood promoted the development of intermittent pneumatic limb compression (IPC) systems that could activate these pumps artificially. The application of IPC to the foot (IPC(foot)), calf (IPC(calf)) or both (IPC(foot + calf)) on dependency generates a significant acute arterial leg inflow enhancement in patients with intermittent claudication that is highest with IPC(foot + calf), followed by IPC(calf) and IPC(foot). This enhancement is attributable to the leg venous pressure decrease after venous expulsion with IPC, which results in arteriovenous pressure elevation, and a marked attenuation in peripheral resistance to flow due to a transient abolition of peripheral sympathetic autoregulation and the release of nitric oxide. Implementation of IPC(foot) and IPC(foot + calf) for 3 to 5 months (> or = 2.5 hours/day) has been shown to improve the walking capacity and the ankle pressure indices of patients with intermittent claudication, with a significant beneficial impact on the quality of life. As the prevalence of symptomatic peripheral arterial disease is projected to increase substantially over the next decades with the aging population in Western societies and in the absence of established, cost-effective methods of treatment for claudication, the reported efficacy of IPC in claudication certainly warrants clinical attention. Level-1 clinical evidence by three independent investigators supports the clinical role of IPC in arterial claudication, reinforced by its domiciliary applicability, the high patient compliance with which it is associated, and the modest cost. This review offers an insight into the hemodynamic and clinical effects of IPC in patients with claudication in relation to the physiologic mechanisms proposed in explanation of these effects.
    MeSH term(s) Blood Flow Velocity ; Homeostasis ; Humans ; Intermittent Claudication/physiopathology ; Intermittent Claudication/therapy ; Intermittent Pneumatic Compression Devices ; Leg/blood supply ; Quality of Life ; Treatment Outcome ; Walking
    Language English
    Publishing date 2005-06-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2054424-8
    ISSN 1521-5768 ; 1531-0035
    ISSN (online) 1521-5768
    ISSN 1531-0035
    DOI 10.1177/153100350501700107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Leg perforator vein incompetence: functional anatomy.

    Delis, Konstantinos T

    Radiology

    2005  Volume 235, Issue 1, Page(s) 327–334

    Abstract: Purpose: To retrospectively determine the anatomic patterns of reflux of incompetent perforator veins (IPVs) at the sites of their highest prevalence in relation to the anatomic distribution of valvular incompetence in the veins of the calf and thigh, ... ...

    Abstract Purpose: To retrospectively determine the anatomic patterns of reflux of incompetent perforator veins (IPVs) at the sites of their highest prevalence in relation to the anatomic distribution of valvular incompetence in the veins of the calf and thigh, with emphasis on the deep system, across the clinical spectrum of chronic venous disease (CVD).
    Materials and methods: This study was granted institutional ethics committee approval; the need for patient consent was waived. Five hundred five limbs in 359 consecutive subjects who were suspected of having CVD but did not have arterial disease, prior venous thrombosis (<1 year), venous or orthopedic surgery, or vascular malformations were clinically stratified for CVD according to the clinical, etiologic, anatomic, and pathophysiologic (CEAP) system and underwent venous hemodynamic investigation with duplex ultrasonography. One hundred thirty limbs were CEAP clinical classes C(0-1), 262 limbs were classes C(2-3), and 113 limbs were classes C(4-6). IPV reflux patterns and anatomic distribution of deep venous reflux in the lower limb were determined across the clinical classes of CVD. Statistical analysis was performed with Spearman rank correlation, chi(2), and Mann-Whitney testing.
    Results: Valvular incompetence in limbs with IPVs increased with CEAP clinical class (P < .01) in femoral, popliteal, posterior tibial, peroneal, gastrocnemial, and soleal veins; reflux was distributed evenly across these veins. Of 554 IPVs found, 377 (68.0%) occurred at four sites: middle third of medial calf (n = 165 [29.8%]), lower third of medial calf (n = 85 [15.3%]), middle third of medial thigh (n = 73 [13.2%]), and middle third of posterior calf (n = 54 [9.7%]). IPVs with superficial and deep reflux in adjoining veins, as compared with IPVs with superficial reflux alone, increased as clinical class increased from C(2) to C(6) (P < .02) at all four sites of highest IPV prevalence; determined in detail, reflux patterns of IPVs were linked to CEAP clinical class (P < .05) but not anatomic site (P > .2). Most IPVs in C(1-3) limbs had superficial reflux alone. IPVs with superficial reflux outnumbered IPVs with superficial and deep reflux even in C(4-6) limbs, where deep venous incompetence was most prevalent. Axial venous reflux (proximal-to-distal) changes (P > .4) were small in superficial and deep veins across the spectrum of CEAP clinical classes C(2-6).
    Conclusion: Patterns of perforator reflux were linked to clinical severity of CVD in the CEAP classification and displayed an even distribution anatomically. IPVs with deep and superficial reflux in adjoining veins increased with CEAP clinical class, in line with valvular incompetence in the deep veins of the calf and thigh.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Venous Insufficiency/pathology ; Venous Insufficiency/physiopathology
    Language English
    Publishing date 2005-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80324-8
    ISSN 1527-1315 ; 0033-8419
    ISSN (online) 1527-1315
    ISSN 0033-8419
    DOI 10.1148/radiol.2351031598
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Perforator vein incompetence in chronic venous disease: a multivariate regression analysis model.

    Delis, Konstantinos T

    Journal of vascular surgery

    2004  Volume 40, Issue 4, Page(s) 626–633

    Abstract: Objectives: In the presence of superficial and deep vein insufficiency the effects, if any, of concurrent incompetent perforator veins (IPVs) on clinical status are masked. On the basis of multivariate regression analysis, this study examines the ... ...

    Abstract Objectives: In the presence of superficial and deep vein insufficiency the effects, if any, of concurrent incompetent perforator veins (IPVs) on clinical status are masked. On the basis of multivariate regression analysis, this study examines the significance of perforator vein incompetence across the clinical classes of CEAP (C-class CEAP ) in relation to the superficial and deep systems, and assesses the role of factors implicated in the presence and number of IPVs in chronic venous disease (CVD).
    Methods: The study included 525 limbs in 360 patients, ages 17 to 96 years, referred for investigation of CVD. The protocol entailed history taking, physical examination, and duplex scanning (reflux > 0.5 s), with emphasis on IPVs. Exclusion criteria included peripheral vascular disease, unrelated edema, severe chronic obstructive pulmonary disease, and recent (< 1 year) deep vein thrombosis (DVT).
    Results: Limbs were stratified as C 0 , 84; C 1 , 25; C 2 , 231; C 3 , 66; C 4 , 48; C 5 , 23; and C 6 , 48. C-class CEAP was separately regressed with age ( P < .001), sex ( P < .25), contralateral CVD ( P < .2), CVD recurrence ( P = .022), previous DVT ( P < .001), superficial vein reflux ( P < .001); deep vein reflux ( P < .001), perforator vein reflux ( P < .001), and number of IPVs ( P < .001). In an optimized multivariate regression analysis of C class CEAP with all significant variables combined, age ( P < .001), previous DVT ( P = .017), superficial vein reflux ( P < .001), deep vein reflux ( P < .001), and number of IPVs ( P = .008) emerged as predictors of CVD severity (CEAP), based on the equation C class CEAP = -0.2807 + 0.028013 Age + 0.58530 Previous DVT + 0.3450 Superficial vein reflux + 0.17781 Deep Reflux + 0.14537 IPVs ( R 2 = 37.4%; P < .001). Perforator incompetence was predicted by superficial vein reflux ( P < .001) and deep vein reflux ( P = .044), age ( P = .019), CVD recurrence ( P = .038), and sex ( P = .018), as follows: Perforator incompetence = -0.2532 + 0.006457 Age + 0.41366 Superficial reflux + 0.06766 Deep reflux + 0.2450 CVD recurrence - 0.21310 Sex ( R 2 = 33.3%; P < .001). Number of IPVs per limb was best associated with superficial reflux ( P < .001) and deep reflux ( P = .023), linked as IPVs = - 0.11789 + 0.41323 Superficial reflux + 0.07646 Deep reflux ( R 2 = 26.1%; P < .001).
    Conclusion: Perforator incompetence proved to be a significant factor for determination of CVD severity according to C-class CEAP , withstanding the conspicuous confounding effects of the superficial and deep venous systems. Perforator incompetence was significantly linked to aging, superficial or deep vein incompetence, recurrence of superficial disease, and sex, whereas the IPV number, regardless of location, depended on the presence of superficial or deep venous reflux.
    MeSH term(s) Adolescent ; Adult ; Chronic Disease ; Female ; Humans ; Lower Extremity/blood supply ; Male ; Middle Aged ; Models, Statistical ; Multivariate Analysis ; Regression Analysis ; Ultrasonography, Doppler ; Veins/diagnostic imaging ; Veins/physiopathology ; Venous Insufficiency/diagnosis
    Language English
    Publishing date 2004-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605700-7
    ISSN 1097-6809 ; 0741-5214
    ISSN (online) 1097-6809
    ISSN 0741-5214
    DOI 10.1016/j.jvs.2004.07.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Α case of seronegative autoimmune encephalitis associated with human herpesvirus-7 (HHV-7).

    Christou, Evangelos / Mastrogianni, Sotiria / Bourousis, Evangelos / Bachou, Theodora / Tsikrikas, Theodoros / Mouskou, Stella / Voudris, Konstantinos / Delis, Dimitrios

    Journal of medical virology

    2021  Volume 94, Issue 2, Page(s) 795–798

    Abstract: In the last 10 years, an increased number of patients presenting with acute encephalitis is being observed, a finding that is attributed to autoimmune mechanisms. Despite the fact that autoantibodies usually target the neuronal cell surface or synaptic ... ...

    Abstract In the last 10 years, an increased number of patients presenting with acute encephalitis is being observed, a finding that is attributed to autoimmune mechanisms. Despite the fact that autoantibodies usually target the neuronal cell surface or synaptic proteins in the central nervous system (CNS), in many cases these remain undetectable, constituting a future diagnostic and therapeutic challenge. Human herpesvirus-7 (HHV-7) is proven to be a neurotropic virus, causing various neurological complications mostly in the adult population. We present the case of a 10-year-old girl, with confirmed active HHV-7 infection of the CNS, who developed acute seronegative autoimmune encephalitis. To our best knowledge, there is no literature concerning pediatric cases of autoimmune encephalitis following HHV-7 infection.
    MeSH term(s) Antibodies, Viral/blood ; Autoantibodies/cerebrospinal fluid ; Autoimmune Diseases of the Nervous System/cerebrospinal fluid ; Brain/pathology ; Child ; Encephalitis/cerebrospinal fluid ; Female ; Herpesvirus 7, Human ; Humans ; Magnetic Resonance Imaging ; Recurrence ; Roseolovirus Infections/cerebrospinal fluid
    Chemical Substances Antibodies, Viral ; Autoantibodies
    Language English
    Publishing date 2021-10-27
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.27411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.

    Panagiotakopoulou, Vasiliki / Botsakis, Konstantinos / Delis, Foteini / Mourtzi, Theodora / Tzatzarakis, Manolis N / Dimopoulou, Aggeliki / Poulia, Nafsika / Antoniou, Katerina / Stathopoulos, Georgios T / Matsokis, Nikolaos / Charalampopoulos, Ioannis / Gravanis, Achilleas / Angelatou, Fevronia

    Neuropharmacology

    2019  Volume 165, Page(s) 107919

    Abstract: BNN-20 is a synthetic microneurotrophin, long-term (P1-P21) administration of which exerts potent neuroprotective effect on the "weaver" mouse, a genetic model of progressive, nigrostriatal dopaminergic degeneration. The present study complements and ... ...

    Abstract BNN-20 is a synthetic microneurotrophin, long-term (P1-P21) administration of which exerts potent neuroprotective effect on the "weaver" mouse, a genetic model of progressive, nigrostriatal dopaminergic degeneration. The present study complements and expands our previous work, providing evidence that BNN-20 fully protects the dopaminergic neurons even when administration begins at a late stage of dopaminergic degeneration (>40%). Since neuroinflammation plays a critical role in Parkinson's disease, we investigated the possible anti-neuroinflammatory mechanisms underlying the pharmacological action of BNN-20. The latter was shown to be microglia-mediated, at least in part. Indeed, BNN-20 induced a partial, but significant, reversal of microglia hyperactivation, observed in the untreated "weaver" mouse. Furthermore, it induced a shift in microglia polarization towards the neuroprotective M2 phenotype, suggesting a possible beneficial shifting of microglia activity. This observation was further supported by morphometric measurements. Moreover, BDNF levels, which were severely reduced in the "weaver" mouse midbrain, were restored to normal even after short-term BNN-20 administration. Experiments in "weaver"/NGL (dual GFP/luciferase-NF-κВ reporter) mice using bioluminescence after a short BNN-20 treatment (P60-P74), have shown that the increase of BDNF production was specifically mediated through the TrkB-PI3K-Akt-NF-κB signaling pathway. Interestingly, long-term BNN-20 treatment (P14-P60) significantly increased dopamine levels in the "weaver" striatum, which seems to be associated with the improved motor activity observed in the treated mutant animals. In conclusion, our findings suggest that BNN-20 may serve as a lead molecule for new therapeutic compounds for Parkinson's disease, combining strong anti-neuroinflammatory and neuroprotective properties, leading to elevated dopamine levels and improved motor activity.
    MeSH term(s) Animals ; Anti-Inflammatory Agents/administration & dosage ; Brain-Derived Neurotrophic Factor/metabolism ; Dehydroepiandrosterone/administration & dosage ; Dehydroepiandrosterone/analogs & derivatives ; Disease Models, Animal ; Dopaminergic Neurons/drug effects ; Dopaminergic Neurons/metabolism ; Encephalitis/complications ; Encephalitis/metabolism ; Encephalitis/prevention & control ; Female ; Male ; Membrane Glycoproteins/metabolism ; Mice, Neurologic Mutants ; Microglia/drug effects ; Microglia/metabolism ; Neuroprotective Agents/administration & dosage ; Parkinson Disease/complications ; Parkinson Disease/metabolism ; Parkinson Disease/prevention & control ; Pars Compacta/drug effects ; Pars Compacta/metabolism ; Protein-Tyrosine Kinases/metabolism ; Tyrosine 3-Monooxygenase/metabolism
    Chemical Substances Anti-Inflammatory Agents ; BNN20 compound ; Bdnf protein, mouse ; Brain-Derived Neurotrophic Factor ; Membrane Glycoproteins ; Neuroprotective Agents ; Dehydroepiandrosterone (459AG36T1B) ; Tyrosine 3-Monooxygenase (EC 1.14.16.2) ; Ntrk2 protein, mouse (EC 2.7.10.1) ; Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2019-12-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218272-5
    ISSN 1873-7064 ; 0028-3908
    ISSN (online) 1873-7064
    ISSN 0028-3908
    DOI 10.1016/j.neuropharm.2019.107919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Neurofibromatosis type 1: from presentation and diagnosis to vascular and endovascular therapy.

    Delis, Konstantinos T / Gloviczki, Peter

    Perspectives in vascular surgery and endovascular therapy

    2006  Volume 18, Issue 3, Page(s) 226–237

    Abstract: Neurofibromatosis type 1, also called von Recklinghausen's disease, is an autosomal dominant disorder linked to chromosome 17, characterized by growth impairment of the neural crest cells (ectoderm) manifested by multiple neural tumors, cutaneous ... ...

    Abstract Neurofibromatosis type 1, also called von Recklinghausen's disease, is an autosomal dominant disorder linked to chromosome 17, characterized by growth impairment of the neural crest cells (ectoderm) manifested by multiple neural tumors, cutaneous pigmentations, and Lisch nodules. Disease phenotype develops with time, making its penetrance almost complete by 5 years of age. Compression of the gastro-intestinal, urinary, or pulmonary tracts by visceral neurofibromas may generate serious complications. Neurofibromatosis type 1 is remarkable for its association with occlusive (stenoses) or aneurysmal arterial disease affecting predominantly the renal arteries and less often the abdominal aorta (middle aortic syndrome), and mesenteric and peripheral arteries. Appraisal of existing literature reveals that timely vascular intervention by way of conventional surgery and/or endovascular therapy may provide patients with effective and durable treatment. The far greater propensity for malignant connective/soft-tissue neoplasms and vascular disease in neurofibromatosis type 1, amid potential complications from the gastro-intestinal, urinary, and pulmonary tracts, leads to a significantly increased morbidity and decreased life expectancy. Neurofibromatosis type 1, from presentation and diagnosis to its treatment, is reviewed, with emphasis on vascular disease and its management with open vascular surgery and endovascular therapy.
    MeSH term(s) Aneurysm/complications ; Humans ; Neurofibromatosis 1/complications ; Neurofibromatosis 1/diagnosis ; Vascular Diseases/complications ; Vascular Surgical Procedures/methods
    Language English
    Publishing date 2006-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2054424-8
    ISSN 1521-5768 ; 1531-0035
    ISSN (online) 1521-5768
    ISSN 1531-0035
    DOI 10.1177/1531003506296488
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment.

    Delis, Konstantinos T / Gloviczki, Peter

    Perspectives in vascular surgery and endovascular therapy

    2005  Volume 17, Issue 3, Page(s) 187–203

    Abstract: Middle aortic syndrome (MAS) is a clinical condition generated by segmental narrowing of the abdominal or distal descending thoracic aorta. MAS may be acquired, caused by Takayasu's or temporal arteritis (giant cell arteritides), neurofibromatosis, ... ...

    Abstract Middle aortic syndrome (MAS) is a clinical condition generated by segmental narrowing of the abdominal or distal descending thoracic aorta. MAS may be acquired, caused by Takayasu's or temporal arteritis (giant cell arteritides), neurofibromatosis, fibromuscular dysplasia, retroperitoneal fibrosis, mucopolysaccharidosis, and the Williams syndrome, or congenital, ascribed to a developmental anomaly in the fusion and maturation of the paired embryonic dorsal aortas. Segmental aortic stenosis may be located at the suprarenal, inter-renal or infrarenal aorta, with a high propensity for concomitant stenoses in both the renal (63%) and visceral (33%) arteries. Hypertension proximal to the aortic stenosis, and relative hypotension distal to it, are characteristic findings in MAS. Typical manifestations include headache, early fatigue on exertion, and bilateral lower-limb claudication. The severity of hypertension is the primary indication for intervention and the factor determining procedural timing. As a great proportion of patients with MAS are children or teenagers, the clinical benefits of early surgical intervention to reverse refractory hypertension have to be weighed against the repercussions pertaining to the insult of surgery on the developing aorta. Open surgery is the primary treatment of tubular aortic narrowing (MAS) associated with renovascular hypertension and visceral artery stenosis. This entails aortoaortic bypass of the diseased segment or, less often, patch aortoplasty and usually bypass grafting of the stenosed renal and visceral arteries performed with autologous conduits, particularly in the youngest of patients. Endovascular therapy may provide a sound minimally invasive treatment in MAS caused by discrete aortic stenoses that do not encompass the mesenteric and renal arteries. Hypertension is thus improved or cured in more than 70% of patients. Prognosis after uncompromised surgical reconstruction is rewarding in the mid and long term in patients with congenital aortic coarctation but deteriorates in patients with aortoarteritis and recurrent inflammatory activity.
    MeSH term(s) Adolescent ; Aorta, Abdominal ; Aorta, Thoracic ; Aortic Diseases/diagnosis ; Aortic Diseases/etiology ; Aortic Diseases/therapy ; Child ; Constriction, Pathologic ; Humans ; Hypertension/etiology ; Hypertension/therapy ; Vascular Surgical Procedures
    Language English
    Publishing date 2005-11-03
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2054424-8
    ISSN 1521-5768 ; 1531-0035
    ISSN (online) 1521-5768
    ISSN 1531-0035
    DOI 10.1177/153100350501700302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-up.

    Delis, Konstantinos T / Nicolaides, Andrew N

    Annals of surgery

    2005  Volume 241, Issue 3, Page(s) 431–441

    Abstract: Summary background data: Perioperative mortality, graft failure, and angioplasty limitations militate against active intervention for claudication. With the exception of exercise programs, conservative treatments yield modest results. Intermittent ... ...

    Abstract Summary background data: Perioperative mortality, graft failure, and angioplasty limitations militate against active intervention for claudication. With the exception of exercise programs, conservative treatments yield modest results. Intermittent pneumatic compression [IPC] of the foot used daily for 3 months enhances the walking ability and pressure indices of claudicants. Although IPC applied to the foot and calf together [IPCfoot+calf] is hemodynamically superior to IPC of the foot, its clinical effects in claudicants remain undetermined.
    Objective: This prospective randomized controlled study evaluates the effects of IPCfoot+calf on the walking ability, peripheral hemodynamics, and quality of life [QOL] in patients with arterial claudication.
    Methods: Forty-one stable claudicants, meeting stringent inclusion and exclusion criteria, were randomized to receive either IPCfoot+calf and aspirin[75 mg] (Group 1; n = 20), or aspirin[75 mg] alone (Group 2; n = 21), with stratification for diabetes and smoking. Groups matched for age, sex, initial [ICD] and absolute [ACD] claudication distances, pressure indices [ABI], popliteal artery flow, and QOL with the short-form 36 Health Survey Questionnaire (SF-36). IPCfoot+calf (120 mm Hg, inflation 4 seconds x 3 impulses per minute, calf inflate delay 1 second) was used for 5 months, > or =2.5 hours daily. Both groups were advised to exercise unsupervised. Evaluation of patients, after randomization, included the ICD and ACD, ABI, popliteal artery flow with duplex and QOL* at baseline*, 1/12, 2/12, 3/12, 4/12, 5/12* and 17/12. Logbooks allowed compliance control. Wilcoxon and Mann-Whitney corrected[Bonferroni] tests were used.
    Results: At 5/12 median ICD, ACD, resting and postexercise ABI had increased by 197%, 212%, 17%, and 64%, respectively, in Group 1 (P < 0.001), but had changed little (P > 0.1) in Group 2; Group 1 had better ICD, ACD, and resting and postexercise ABI (P < 0.01) than Group 2. Inter- and intragroup popliteal flow differences at 5/12 were small (P > 0.1). QOL had improved significantly in Group 1 but not in Group 2; QOL in the former was better (P < 0.01) than in Group 2. QOL in Group 1 was better (P < 0.01) than in Group 2 at 5/12. IPC was complication free. IPC compliance (> or =2.5 hours/d) was >82% at 1 month and >85% at 3 and 5 months. ABI and walking benefits in Group 1 were maintained a year after cessation of IPC treatment.
    Conclusions: IPCfoot+calf emerged as an effective, high-compliance, complication-free method for improving the walking ability and pressure indices in stable claudication, with a durable outcome. These changes were associated with a significant improvement in all aspects of QOL evaluated with the SF-36. Despite some limited benefit noted in some individuals, unsupervised exercise had a nonsignificant impact overall.
    MeSH term(s) Aged ; Aged, 80 and over ; Aspirin/administration & dosage ; Blood Flow Velocity ; Exercise Test ; Female ; Follow-Up Studies ; Foot ; Humans ; Intermittent Claudication/physiopathology ; Intermittent Claudication/therapy ; Intermittent Pneumatic Compression Devices ; Leg/blood supply ; Male ; Middle Aged ; Popliteal Artery ; Quality of Life ; Walking
    Chemical Substances Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2005-02-22
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 340-2
    ISSN 1528-1140 ; 0003-4932
    ISSN (online) 1528-1140
    ISSN 0003-4932
    DOI 10.1097/01.sla.0000154358.83898.26
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top